125 related articles for article (PubMed ID: 35932528)
1. Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and MYBL2 on Ras/ErbB signaling.
Zhong F; Chen T; Li B
Biochem Biophys Res Commun; 2022 Sep; 622():170-176. PubMed ID: 35932528
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
[TBL] [Abstract][Full Text] [Related]
3. MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.
Musa J; Aynaud MM; Mirabeau O; Delattre O; Grünewald TG
Cell Death Dis; 2017 Jun; 8(6):e2895. PubMed ID: 28640249
[TBL] [Abstract][Full Text] [Related]
4. YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cells.
Wei T; Weiler SME; Tóth M; Sticht C; Lutz T; Thomann S; De La Torre C; Straub B; Merker S; Ruppert T; Marquardt J; Singer S; Gretz N; Schirmacher P; Breuhahn K
Oncogene; 2019 Jul; 38(27):5541-5550. PubMed ID: 30936457
[TBL] [Abstract][Full Text] [Related]
5. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
6. Downstream Regulatory Network of MYBL2 Mediating Its Oncogenic Role in Melanoma.
Zhong F; Liu J; Gao C; Chen T; Li B
Front Oncol; 2022; 12():816070. PubMed ID: 35664780
[TBL] [Abstract][Full Text] [Related]
7. The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer.
Li X; Zhang X; Wu CC; Li PP; Fu YM; Xie LH; Sun SS; Zhou YY; Zhu BL
J Mol Histol; 2021 Feb; 52(1):21-30. PubMed ID: 33141360
[TBL] [Abstract][Full Text] [Related]
8. MYBL2 Is Targeted by miR-143-3p and Regulates Breast Cancer Cell Proliferation and Apoptosis.
Chen J; Chen X
Oncol Res; 2018 Jul; 26(6):913-922. PubMed ID: 29268817
[TBL] [Abstract][Full Text] [Related]
9. Actin-binding Rho activating C-terminal like (ABRACL) transcriptionally regulated by MYB proto-oncogene like 2 (MYBL2) promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of breast cancer cells.
Li J; Chen H
Bioengineered; 2022 Apr; 13(4):9019-9031. PubMed ID: 35341461
[TBL] [Abstract][Full Text] [Related]
10. MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
Zhao JZ; Wang W; Liu T; Zhang L; Lin DZ; Yao JY; Peng X; Jin G; Ma TT; Gao JB; Huang F; Nie J; Lv Q
BMC Cancer; 2022 Dec; 22(1):1290. PubMed ID: 36494680
[TBL] [Abstract][Full Text] [Related]
11. High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma.
Guan Z; Cheng W; Huang D; Wei A
Curr Res Transl Med; 2018 Mar; 66(1):27-32. PubMed ID: 29274707
[TBL] [Abstract][Full Text] [Related]
12. MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3.
Liu W; Shen D; Ju L; Zhang R; Du W; Jin W; Xiong K; Wang G; Qian K; Zhang Y; Xiao Y; Wang X
Oncogene; 2022 Oct; 41(41):4606-4617. PubMed ID: 36071275
[TBL] [Abstract][Full Text] [Related]
13. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
[No Abstract] [Full Text] [Related]
14. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
15. The zinc finger E-box-binding homeobox 1 (
Yan L; Li Y; Shi Z; Lu X; Ma J; Hu B; Jiao J; Wang H
J Biol Chem; 2017 Aug; 292(31):12959-12970. PubMed ID: 28500132
[TBL] [Abstract][Full Text] [Related]
16. MYBL2 is a new regulator of flavonoid biosynthesis in Arabidopsis thaliana.
Dubos C; Le Gourrierec J; Baudry A; Huep G; Lanet E; Debeaujon I; Routaboul JM; Alboresi A; Weisshaar B; Lepiniec L
Plant J; 2008 Sep; 55(6):940-53. PubMed ID: 18532978
[TBL] [Abstract][Full Text] [Related]
17. HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma.
Li L; Zheng YL; Jiang C; Fang S; Zeng TT; Zhu YH; Li Y; Xie D; Guan XY
Cell Death Differ; 2019 Nov; 26(11):2268-2283. PubMed ID: 30778199
[TBL] [Abstract][Full Text] [Related]
18. CBFA2T3-ZNF652 corepressor complex regulates transcription of the E-box gene HEB.
Kumar R; Cheney KM; McKirdy R; Neilsen PM; Schulz RB; Lee J; Cohen J; Booker GW; Callen DF
J Biol Chem; 2008 Jul; 283(27):19026-38. PubMed ID: 18456661
[TBL] [Abstract][Full Text] [Related]
19. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
[TBL] [Abstract][Full Text] [Related]
20. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]